Bio-Techne Faces Earnings Pressure as Biotech Spending Remains Soft

According to reporting from Yahoo Finance, Bio-Techne Corporation is preparing to release fiscal fourth-quarter results amid expectations of a nearly ten percent drop in earnings per share. High demand from major pharmaceutical clients has not yet fully bridged the gap created by

According to reporting from Yahoo Finance, Bio-Techne Corporation is preparing to release fiscal fourth-quarter results amid expectations of a nearly ten percent drop in earnings per share. High demand from major pharmaceutical clients has not yet fully bridged the gap created by